Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Petrelli

Showing results (81-90 of 304) with videos related to

Pageof 31
Sort By:
The Oncologist|April 26, 2012
The risk for anemia with targeted therapies for solid tumorsSandro Barni, Mary Cabiddu, Paolo Guarneri, et al.
Breast Cancer Research and Treatment|October 15, 2018
One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysisAlessandro Inno, Sandro Barni, Antonio Ghidini, et al.
Medical Oncology (Northwood, London, England)|August 22, 2018
Patient performance status and cancer immunotherapy efficacy: a meta-analysisMelissa Bersanelli, Matteo Brighenti, Sebastiano Buti, et al.
Cancer Immunology, Immunotherapy : CII|November 10, 2020
Efficacy of immune checkpoint inhibitors in elderly patients aged ≥ 75 yearsFausto Petrelli, Alessandro Inno, Antonio Ghidini, et al.
Urology|August 13, 2016
Prognostic Factors of Overall Survival in Upper Urinary Tract Carcinoma: A Systematic Review and Meta-analysisFausto Petrelli, Mohamed Ismail Yasser Hussein, Ivano Vavassori, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2025
An umbrella review of meta-analyses on smoking cessation and cancer survival: a brief reportFausto Petrelli, Antonio Ghidini, Mauro Rossitto, et al.
Biomedicines|March 28, 2026
Ocular Toxicities of Anticancer Therapies in the Era of Precision Oncology: A Practical, Clinically Oriented Narrative ReviewFausto Meriggi, Ester Oneda, Sara Cherri, et al.
Gynecologic Oncology|May 6, 2014
Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysisFausto Petrelli, Agostina De Stefani, Francesco Raspagliesi, et al.
Current Oncology Reports|July 6, 2026
Next-Generation Checkpoint Combinations: Optimizing PD-(L)1-Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant SettingsFausto Petrelli, Lara Colombo Zefinetti, Andrea D'Alessio, et al.
Tumori|September 27, 2022
Outcome of non-small-cell lung cancer with driven mutations treated with anti-PD-(L)1 agents: A systematic reviewAndrea Luciani, Antonio Ghidini, Karen Borgonovo, et al.
Pageof 31

Showing results (81-90 of 304) with videos related to

Sort By:
Pageof 31
The Oncologist|April 26, 2012
The risk for anemia with targeted therapies for solid tumorsSandro Barni, Mary Cabiddu, Paolo Guarneri, et al.
Breast Cancer Research and Treatment|October 15, 2018
One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysisAlessandro Inno, Sandro Barni, Antonio Ghidini, et al.
Medical Oncology (Northwood, London, England)|August 22, 2018
Patient performance status and cancer immunotherapy efficacy: a meta-analysisMelissa Bersanelli, Matteo Brighenti, Sebastiano Buti, et al.
Cancer Immunology, Immunotherapy : CII|November 10, 2020
Efficacy of immune checkpoint inhibitors in elderly patients aged ≥ 75 yearsFausto Petrelli, Alessandro Inno, Antonio Ghidini, et al.
Urology|August 13, 2016
Prognostic Factors of Overall Survival in Upper Urinary Tract Carcinoma: A Systematic Review and Meta-analysisFausto Petrelli, Mohamed Ismail Yasser Hussein, Ivano Vavassori, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2025
An umbrella review of meta-analyses on smoking cessation and cancer survival: a brief reportFausto Petrelli, Antonio Ghidini, Mauro Rossitto, et al.
Biomedicines|March 28, 2026
Ocular Toxicities of Anticancer Therapies in the Era of Precision Oncology: A Practical, Clinically Oriented Narrative ReviewFausto Meriggi, Ester Oneda, Sara Cherri, et al.
Gynecologic Oncology|May 6, 2014
Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysisFausto Petrelli, Agostina De Stefani, Francesco Raspagliesi, et al.
Current Oncology Reports|July 6, 2026
Next-Generation Checkpoint Combinations: Optimizing PD-(L)1-Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant SettingsFausto Petrelli, Lara Colombo Zefinetti, Andrea D'Alessio, et al.
Tumori|September 27, 2022
Outcome of non-small-cell lung cancer with driven mutations treated with anti-PD-(L)1 agents: A systematic reviewAndrea Luciani, Antonio Ghidini, Karen Borgonovo, et al.
Pageof 31